112 related articles for article (PubMed ID: 7828183)
1. The out of stock syndrome.
Matenga JA
Cent Afr J Med; 1994 Oct; 40(10):291-2. PubMed ID: 7828183
[No Abstract] [Full Text] [Related]
2. The prickly problem of access to insulin.
Cohen D
BMJ; 2011 Sep; 343():d5782. PubMed ID: 21917833
[No Abstract] [Full Text] [Related]
3. Diabetes in the developing world.
Savage A
Lancet; 1993 Apr; 341(8849):900. PubMed ID: 8096605
[No Abstract] [Full Text] [Related]
4. Diabetes in the developing world.
Lakhani Z
BMJ; 1995 Feb; 310(6976):403. PubMed ID: 7866240
[No Abstract] [Full Text] [Related]
5. Insulin: availability and cost.
Alberti KG
World Health Forum; 1994; 15(4):376-7. PubMed ID: 7999231
[No Abstract] [Full Text] [Related]
6. Epidemiology and costs of diabetes treated with insulin in France.
Detournay B; Raccah D; Cadilhac M; Eschwège E
Diabetes Metab; 2005 Jun; 31(3 Pt 2):3-18. PubMed ID: 16142041
[TBL] [Abstract][Full Text] [Related]
7. Diabetes costs rise, but so does adherence.
Manag Care; 2005 Apr; 14(4):54. PubMed ID: 15898213
[No Abstract] [Full Text] [Related]
8. Insulin 1996--75 years after its discovery.
Jervell J
Diabet Med; 1996 Oct; 13(10):847-9. PubMed ID: 8911776
[No Abstract] [Full Text] [Related]
9. [Costs of the treatment of hyperglycemia in patients with diabetes mellitus. The impact of age, type of therapy and complications: results of the German CoDiM study].
von Ferber L; Köster I; Hauner H
Med Klin (Munich); 2006 May; 101(5):384-93. PubMed ID: 16685485
[TBL] [Abstract][Full Text] [Related]
10. [The changeover to insulin U100. Clinical and pharmacoeconomic suggestions].
Costa B
Med Clin (Barc); 1996 Apr; 106(13):495-7. PubMed ID: 8992131
[No Abstract] [Full Text] [Related]
11. Economics of insulin.
Shah SN
J Assoc Physicians India; 2007 Jul; 55 Suppl():67-70. PubMed ID: 17927015
[No Abstract] [Full Text] [Related]
12. Expenditures and Prices of Antihyperglycemic Medications in the United States: 2002-2013.
Hua X; Carvalho N; Tew M; Huang ES; Herman WH; Clarke P
JAMA; 2016 Apr; 315(13):1400-2. PubMed ID: 27046369
[No Abstract] [Full Text] [Related]
13. [Without short acting insulin analogs. Is therapy quality really maintained? (interview by Dirk Einecke)].
Lüddeke HJ
MMW Fortschr Med; 2006 Sep; 148(37):9. PubMed ID: 17036893
[No Abstract] [Full Text] [Related]
14. Cost-effectiveness of intense insulin treatment after acute myocardial infarction in patients with diabetes mellitus; results from the DIGAMI study.
Almbrand B; Johannesson M; Sjöstrand B; Malmberg K; Rydén L
Eur Heart J; 2000 May; 21(9):733-9. PubMed ID: 10739728
[TBL] [Abstract][Full Text] [Related]
15. PHARMAC and long-acting insulin analogues: a poor man's insulin pump--but not available to the poor man.
Krebs J
N Z Med J; 2005 Aug; 118(1221):U1641. PubMed ID: 16138177
[TBL] [Abstract][Full Text] [Related]
16. Comment and reply on: Relative efficacy/effectiveness and relative costs of treatment with insulin glargine and insulin detemir.
Freemantle N; Stella P; Munro V
Curr Med Res Opin; 2007 Aug; 23(8):1761-2; author reply 1762-4. PubMed ID: 17588305
[No Abstract] [Full Text] [Related]
17. Insulin for the world's poorest countries.
Teuscher A; Wiedenmayer K; Teuscher T
Lancet; 2000 Jun; 355(9221):2166-7. PubMed ID: 10902657
[No Abstract] [Full Text] [Related]
18. [Epidemiology and costs of diabetes mellitus in Germany].
Hauner H
Dtsch Med Wochenschr; 2005 Jul; 130 Suppl 2():S64-5. PubMed ID: 15988670
[No Abstract] [Full Text] [Related]
19. Insulin lispro, a new insulin analog.
Kucera ML; Graham JP
Pharmacotherapy; 1998; 18(3):526-38. PubMed ID: 9620104
[TBL] [Abstract][Full Text] [Related]
20. [Statistical analytical methods in the study of requirements for antidiabetic drugs of the population of the Lvov region].
Kurash PD
Farm Zh; 1969; 24(6):8-12. PubMed ID: 5378209
[No Abstract] [Full Text] [Related]
[Next] [New Search]
